Haiyan Fu
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$2.1MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $2.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 12, 2026 | NIH | STTR Phase I Novel AAV gene therapy for treating CNS neuropathy of MPS IIIC | $343K | NEUROGT INC |
| Jul 8, 2025 | NIH | STTR Phase I Novel AAV gene therapy for treating CNS neuropathy of MPS IIIC | $350K | NEUROGT INC |
| Aug 16, 2023 | NIH | STTR Phase I Develop AAV9 gene replacement therapy for treating MPS I | $324K | NEUROGT INC |
| Jul 29, 2022 | NIH | STTR Phase I Develop AAV9 gene replacement therapy for treating MPS I | $379K | NEUROGT INC |
| Mar 30, 2021 | NIH | STTR Phase I Development of gene therapy product for treating MPS IIIB | $284K | NEUROGT INC |
| Apr 7, 2020 | NIH | STTR Phase I Development of gene therapy product for treating MPS IIIB | $398K | NEUROGT INC |
Peer ranks
Federal funding#952
Awards as PI#315
Patents#273
Companies
- NEUROGT INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.